The DICOMIT Dicom Image Manager medical image management system is intended for acceptance, transfer, display, storage and digital processing of medical images. The software component provides functions for performing operations related to image manipulation.

The "3D ROI" software option enables the device to display and manipulate an adjunctive 3D volume image created with data from a diagnostic ultrasound scanning procedure.

Device Description

The software changes described in this submission enable the DICOMIT Dicom Image Manager - with 3D-visualization software module to store in memory, multiple sequential ultrasound images when using a standard ultrasound transducer during any standard ultrasound scanning procedure. These images can then be rendered as a 3D image that can be displayed and manipulated in "windows" on the monitor.

AI/ML Overview

The provided text describes a 510(k) premarket notification for the DICOMIT Dicom Image Manager - Addition of 3D Visualization Software Module. However, it does not contain information about acceptance criteria, device performance studies, sample sizes, expert ground truth establishment, or multi-reader multi-case studies.

The document focuses on:

Identifying the submitter and device.
Classifying the device and its intended use.
Comparing it to predicate devices to establish substantial equivalence.
The FDA's decision to clear the device based on substantial equivalence.

Therefore, I cannot provide the requested table and details because the information is not present in the given text. The FDA clearance is based on substantial equivalence to existing devices, implying that detailed performance studies might not have been required for this specific 510(k) submission, as the fundamental technology and intended use were deemed similar to devices already on the market.

Summary

{0}------------------------------------------------

4/16/99

Page A - 4 510(k) Notification DICOM IMAGE MANAGER - Addition of 3D Visualization Software Module 510 (k) SUMMARY

K990248

This following summary is provided as part of this Premarket Notification in compliance with and based on the format set forth in the Final Rule as published in the Federal Register, December 14, 1994. (See 21 CFR § 807.92)

(1) Submitters Name / Contact Person:

Dicomit Imaging Systems Corp. 75 East Beaver Creek Road, Unit 9 Richmond Hill, Ontario Canada L4B 1K6

Contact Person:	Terry Callahan
	Tel.: (905) 886-9496
	Fax: (905) 886-2109
	E-mail: tcallahan@dicomit.com

January 22, 1999 Date prepared:

(2) Name of device:

Trade Name:	Dicom Image Manager™ "3D ROI™"
Common Name:	3D Visualization Module
Classification Name:	Ultrasonic Pulsed Echo Imaging System

(3) Identification of predicate devices:

Manufacturer	Device	510(k) Number
Dicomit Imaging Systems Corp.	Dicom Image Manager	K951925
Advanced Technology Labs	ATL HDI 3000/5000 Ultrasound systems	K961459
General Electric Medical Systems	GE LOGIQ 700 Ultrasound system	K964617

(4) Description of the device:

{1}------------------------------------------------

Page A - 5 510(k) Notification DICOM IMAGE MANAGER - Addition of 3D Visualization Software Module

(5) A statement of the intended use of the device:

The "3D ROI" software option enables the device to display and manipulate an adjunctive 3D volume image created with data from a diagnostic ultrasound scanning procedure.

(6) Predicate Device Comparison:

The DICOMIT Dicom Image Manager - with 3D Visualization Software Module is substantially equivalent to similar features in the predicate devices and has the same intended uses and technological characteristics as the predicate devices.

The DICOMIT system and the predicate devices all use standard ultrasound system probes. All systems acquire multiple sequential images scanned in a "freehand" manner by the user without special positioning devices or position sensors.

The resulting sequential images are stored in the ultrasound system memory commonly called "Cine" or "Cine Loop". On all three systems the 3D volume images are rendered using the individual B-mode scan images acquired from the "freehand" scan.

The DICOMIT Dicom Image Manager - with 3D Visualization Software Module creates a 3D volume image in the same manner as the predicate devices described in this submission.

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an image of an abstract eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

APR 1 6 1999

Terry Callahan President Dicomit Imaging Systems Corp. 75 East Beaver Creek Rd., Unit 9 Richmond Hill. Ontario Canada L4B 1K6

Re:

K990248 DICOM Image Manager, 3D Visualization Option "3D ROI" Dated: January 22, 1999 Received: January 26, 1999 Regulatory class: II 21 CFR 892_1560/Procode: 90 IYO

Dear Mr. Callahan:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marked predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the requlation entitled. "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,

APT Daniel G. Schultz, M.D. Acting Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

Page 5 510(k) Notification DICOM IMAGE MANAGER Addition of 3D Visualization Software Module

510(k) Number (if Known): K990248

Device Name: DICOMIT Dicom Image Manager "3D ROI" Option

Indications For Use:

The "3D ROI" software option enables the device to display and manipulate an adjunctive 3D volume image created with data from a diagnostic ultrasound scanning procedure.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Over-The-Counter Use

(Optional Format 1-2-96)

Dmeld W. Slu for DDS

vision Sion Off ivision of Reproductive, Abdominal, EN and Radiological C 510(k) Number

Regulation Number and Section

§ 892.1560 Ultrasonic pulsed echo imaging system.

(a)
Identification. An ultrasonic pulsed echo imaging system is a device intended to project a pulsed sound beam into body tissue to determine the depth or location of the tissue interfaces and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A biopsy needle guide kit intended for use with an ultrasonic pulsed echo imaging system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.